News

Dermatophytoses are common but often under-discussed due to their perceived lack of interest. Clinical inspection alone is inadequate for diagnosing dermatophytoses, as demonstrated by Friedman's image-based competition. Potassium hydroxide prep is recommended to distinguish dermatophyte…

Experts say the 23 products can help improve dark spots, fine lines, dry skin, and more.

Despite the growing use of fully ablative laser resurfacing for photodamaged skin, standard protocols for managing adverse events remain limited. A newly published international consensus statement now aims to close that gap.

Published in the June 2025 issue of Lasers in Surgery and…

Despite its small body surface area involvement, chronic hand eczema (CHE) represents a significant dermatologic and socioeconomic burden. In a recent session on chronic hand eczema (CHE) Socity of Dermatology Physician Associates (SDPA) 2025 Summer Conference given by Adam Friedman, MD, FAAD,…

Adam Friedman, MD, FAAD, breaks down how to differentiate chronic hand eczema from similar conditions using history, morphology, and key clinical clues.

This interview segment at the 2025 SDPA Conference highlights additional insights by Friedman on the management and diagnosis of chronic hand eczema, or CHE.

Renata Block, DMSc, MMS, PA-C, speaks with Adam Friedman, MD, FAAD, on innovative teledermatology initiatives in Washington, DC, addressing health care disparities and enhancing community access.

In part 3 of this conversation, Dr. Adam Friedman, MD, FAAD, discusses the need for unity in advancing lichen planus care and research.

In part 2 of this conversation, Adam Friedman, MD, FAAD, discusses new data on lichen planus treatment trends, unmet needs, and the promise of innovative therapies.

Dr. Friedman discusses survey findings revealing inconsistent screening, outdated assumptions, and lack of FDA-approved therapies for lichen planus.